CT Behavioral Health Associates partnered with us to scale their Esketamine program using a specialized paid media framework combined with an internal care-coordination system.
Key outcomes so far:
- 1,119 total leads generated
- 136 evaluations scheduled
- 72 qualified eval shows
- 54 prior authorizations approved
- 37 patients converted so far
- Projected revenue: $400,000+
- Total ad spend: ~$6,500
- 20% of the clinic’s entire active Spravato patient base came directly from our campaigns
The clinic currently has 180 active Spravato patients, and we generated 20% of them, demonstrating the long-term compounding impact of our system.
1. The Starting Point (First 60 Days)
Ad Spend
- $2,754.97 invested in Meta Ads
Performance
- 485 leads generated
- CPL: $5.68
- 65 evaluations scheduled
Conversion Metrics
- Lead → Eval Conversion: 65 ÷ 485 = 13.4%
- Eval → Patient Conversion: 25 ÷ 65 = 38.46%
Revenue Impact (First 2 Months)
- 25 patients × $7,500 LTV = $187,500 projected revenue
2. Month 3 – Pausing to Expand Clinic Capacity
In Month 3, the demand we generated exceeded the clinic’s operational capacity.
We mutually agreed to intentionally slow down campaigns while they hired and trained additional staff.
Even with the slowdown, we still booked:
- 10 evaluations
This ensured sustainable scaling without sacrificing patient experience or clinical workflow.
3. October & November – Scaling Again
Once capacity was restored, we resumed scaling.
Results
- 61 evaluations booked (Oct + Nov combined)
- Consistently 2× the client’s evaluation target every month
Stable CPL and high treatment qualification rates
4. Total Results To Date
Lead & Evaluation Performance
- 1,119 total leads
- 136 total evaluations
Lead → Eval Conversion: 136 ÷ 1,119 = 12.15%
Evaluation Funnel Breakdown
- 72 qualified eval shows
- 54 prior authorizations approved
- 37 patients converted so far
Revenue Impact So Far
- 37 patients × $7,500 LTV = $277,500
Projected Revenue
Many evals are still:
- Awaiting PA approval
- Scheduled for future dates
- In insurance submission
With a conservative 35% projected conversion of remaining evals:
- Total projected revenue surpasses $400,000
Achieved with only ~$6,500 in total ad spend
5. Additional Wins: TMS Growth
At one point, the clinic shared concerns that they were not receiving enough TMS patients. We quickly adjusted:
- Targeting
- Messaging
- Funnel structure
Outcome:
They are now consistently receiving more TMS leads and evaluations, aligned with their operational bandwidth and treatment goals.
6. Why This Worked
This level of growth was driven by two combined forces:
A. Specialized Healthcare Media Buying
- Advanced Meta structures optimized for behavioral health
- Qualification-first strategy (insurance, PA suitability, treatment fit)
- Continuous creative and audience testing
- Low CPL + high evaluation volume
B. Integrated Care Coordination
- Guaranteed minimum 12 evaluations/month in the first 90 days
- Structured follow-up for high show rates
- Efficient PA support leading to strong patient conversion
Together, these systems ensure not just leads, but real patients, real revenue, and scalable clinical capacity.
7. Conclusion
CT Behavioral Health Associates transformed their Spravato program into a high-performing, predictable, and scalable service line. With:
- More than 20% of their active Spravato patients coming from our campaigns
- Over $400,000 in projected revenue
- Only $6,500 in ad spend
They now have a reliable pipeline of both Esketamine and TMS patients and a growth model built to sustain long-term expansion.
